Neural correlates in functional brain mapping among breast cancer survivors receiving different chemotherapy regimens: a qEEG/HEG-based investigation.

Maryam Vasaghi GharamalekiSeyedeh Zahra MousaviMaryam OwrangiMohammad Javad GholamzadehAli-Mohammad KamaliMehdi DehghaniPrasun ChakrabartiMohammad Nami

Published in: Japanese journal of clinical oncology (2022)

The negatively affected neurocognitive profile in breast cancer patients treated with the Adriamycin, Cyclophosphamide and Taxol regimen proposes presumably neurotoxic sequelae of this chemotherapy regimen as compared with the Taxotere, Adriamycin and Cyclophosphamide regimen.

Keyphrases

high dose
low dose
locally advanced
high resolution
squamous cell carcinoma
multiple sclerosis
rectal cancer
radiation therapy
young adults
mass spectrometry
chemotherapy induced
high density
brain injury
cerebral ischemia
subarachnoid hemorrhage
breast cancer risk